RESEARCHER PROFILE
Lanying Du
← Back to Georgia State University
L
Georgia State University
Lanying Du works in SARS-CoV-2 and COVID-19 Research, Animal Virus Infections Studies, vaccines and immunoinformatics approaches, Influenza Virus Research Studies, Monoclonal and Polyclonal Antibodies Research. Recorded institutional associations include Georgia State University.
196Publications
19,510Citations
70H-index
Inclusion identifies researchers whose recorded research contributions may inform their university’s understanding of its research community. It does not rank individual research quality or establish current employment.
Selected research works
Up to 100 highly cited works; DOI links open the original research. Counts reflect the collected record, not real-time citation totals.
The spike protein of SARS-CoV — a target for vaccine and therapeutic development
2009 · 1,661 citationsCharacterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine
2020 · 1,650 citationsInhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion
2020 · 1,343 citationsNeutralizing Antibodies against SARS-CoV-2 and Other Human Coronaviruses
2020 · 847 citationsMolecular Mechanism for Antibody-Dependent Enhancement of Coronavirus Entry
2019 · 662 citationsRecent advances in the detection of respiratory virus infection in humans
2020 · 550 citationsA pan-coronavirus fusion inhibitor targeting the HR1 domain of human coronavirus spike
2019 · 501 citationsSubunit Vaccines Against Emerging Pathogenic Human Coronaviruses
2020 · 425 citationsStructure-based discovery of Middle East respiratory syndrome coronavirus fusion inhibitor
2014 · 388 citationsMeasures for diagnosing and treating infections by a novel coronavirus responsible for a pneumonia outbreak originating in Wuhan, China
2020 · 366 citationsAn emerging coronavirus causing pneumonia outbreak in Wuhan, China: calling for developing therapeutic and prophylactic strategies
2020 · 330 citationsSevere acute respiratory syndrome-associated coronavirus 3a protein forms an ion channel and modulates virus release
2006 · 321 citationsMERS-CoV spike protein: a key target for antivirals
2016 · 299 citationsReceptor usage and cell entry of bat coronavirus HKU4 provide insight into bat-to-human transmission of MERS coronavirus
2014 · 281 citationsReceptor Usage and Cell Entry of Porcine Epidemic Diarrhea Coronavirus
2015 · 259 citationsExceptionally Potent Neutralization of Middle East Respiratory Syndrome Coronavirus by Human Monoclonal Antibodies
2014 · 233 citationsNeutralizing Antibodies against SARS-CoV-2 and Other Human Coronaviruses
2020 · 199 citationsBlockade of the C5a–C5aR axis alleviates lung damage in hDPP4 -transgenic mice infected with MERS-CoV
2018 · 195 citationsReceptor-binding domain of SARS-CoV spike protein induces long-term protective immunity in an animal model
2006 · 182 citationsIdentification of a Receptor-Binding Domain in the S Protein of the Novel Human Coronavirus Middle East Respiratory Syndrome Coronavirus as an Essential Target for Vaccine Development
2013 · 178 citationsLearning from the past: development of safe and effective COVID-19 vaccines
2020 · 170 citationsIn silico design of a DNA-based HIV-1 multi-epitope vaccine for Chinese populations
2015 · 158 citationsCurrent advancements and potential strategies in the development of MERS-CoV vaccines
2014 · 158 citationsA Truncated Receptor-Binding Domain of MERS-CoV Spike Protein Potently Inhibits MERS-CoV Infection and Induces Strong Neutralizing Antibody Responses: Implication for Developing Therapeutics and Vaccines
2013 · 157 citationsA novel receptor-binding domain (RBD)-based mRNA vaccine against SARS-CoV-2
2020 · 149 citations
